DADC
RDHL

D.A. Davidson & Co’s Redhill Biopharma RDHL Stock Holding History

D.A. Davidson & Co’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11
Closed -$1.47K – 1401
2022
Q4 		$1.47K Hold
11
– – ﹤0.01% 1317
2022
Q3 		$5K Sell
11
-4
-27% -$3.48K ﹤0.01% 1279
2022
Q2 		$13K Sell
15
-2
-12% -$2.74K ﹤0.01% 1268
2022
Q1 		$42K Hold
17
– – ﹤0.01% 1271
2021
Q4 		$43K Hold
17
– – ﹤0.01% 1254
2021
Q3 		$77K Sell
17
-13
-43% -$88.2K ﹤0.01% 1190
2021
Q2 		$205K Hold
30
– – ﹤0.01% 1125
2021
Q1 		$218K Hold
30
– – ﹤0.01% 1065
2020
Q4 		$241K Buy
30
+11
+58% +$98.9K ﹤0.01% 919
2020
Q3 		$197K Buy
19
+2
+12% +$16.4K ﹤0.01% 886
2020
Q2 		$111K Buy
17
+6
+55% +$41.3K ﹤0.01% 901
2020
Q1 		$50K Buy
+11
New +$55K ﹤0.01% 961
2019
Q4 		– Sell
-25
Closed -$174K – 1055
2019
Q3 		$174K Sell
25
-1
-4% -$7.28K ﹤0.01% 933
2019
Q2 		$167K Sell
26
-5
-16% -$38.5K ﹤0.01% 918
2019
Q1 		$258K Hold
31
– – ﹤0.01% 946
2018
Q4 		$172K Sell
31
-3
-9% -$23K ﹤0.01% 1006
2018
Q3 		$296K Hold
34
– – 0.01% 913
2018
Q2 		$286K Buy
34
+2
+6% +$12.7K 0.01% 894
2018
Q1 		$162K Sell
32
-7
-18% -$40.3K ﹤0.01% 1026
2017
Q4 		$200K Sell
39
-5
-11% -$33.7K ﹤0.01% 1016
2017
Q3 		$475K Hold
44
– – 0.01% 693
2017
Q2 		$379K Buy
44
+4
+10% +$38.5K 0.01% 713
2017
Q1 		$383K Buy
40
+3
+8% +$30K 0.01% 702
2016
Q4 		$387K Buy
37
+10
+37% +$120K 0.01% 740
2016
Q3 		$368K Buy
+27
New +$378K 0.01% 732

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

D.A. Davidson & Co's RDHL Position: Q1 2023 in Review

D.A. Davidson & Co sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 11 shares — an estimated $1.47K sold.

D.A. Davidson & Co first reported a position in RDHL in Q3 2016 and held it in 25 quarters. The position peaked at $475K in Q3 2017. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • D.A. Davidson & Co reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • D.A. Davidson & Co sold 11 Redhill Biopharma shares in Q1 2023, an estimated $1.47K.
  • D.A. Davidson & Co first reported a position in Redhill Biopharma in Q3 2016 and held it in 25 quarters.
  • D.A. Davidson & Co's Redhill Biopharma position peaked at $475K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on D.A. Davidson & Co's 13F filing for Q1 2023, filed 25 Apr 2023.